When the lights dimmed on October 9, two very different movies entered the same theatrical arena. Universal’s low-budget horror vehicle Other Mommy opened in 3,200 North American venues and generated roughly $27.5 million domestically, while Sony’s much-hyped tech thriller The Social Reckoning struggled to reach $5.5 million across 2,606 screens. The contrast between the two openings underscores how genre, marketing hooks, and audience sentiment can outweigh star power and pedigree in a single weekend.
Box-office numbers in detail
The horror title’s opening day pulled in $12.6 million in the United States and Canada, followed by $8.9 million on Saturday and $5.9 million on Sunday. International markets added another $17.6 million, bringing the global total to $45.1 million after three days. By comparison, The Social Reckoning opened with $2.2 million domestically, added $1.7 million on its second day and $1.4 million on the third, while overseas territories contributed roughly $3 million, for a worldwide haul of $9 million.
Both films were released against a crowded slate that included the second-week run of Verity the fourth weekend of the Resident Evil reboot, and the limited-release documentary Musk. Yet only Other Mommy managed to secure the top spot in the domestic box-office rankings, pushing the previous week’s horror leader, Tron: Ares further down the list.
Critical response and audience sentiment
Despite its commercial success, Other Mommy has been pummeled by critics. Rotten Tomatoes records a 19 % approval rating, and CinemaScore reported a dismal D+ — the lowest grade for any wide-release film since 2024’s Megalopolis. Reviewers described the movie as a collection of “jumpy bits and half-baked mythology,” noting that the trailer’s shock value was the primary driver of early interest. Nevertheless, the film’s modest $19 million production budget means that even a lukewarm audience turnout translates into a solid profit margin.
In contrast, The Social Reckoning earned a modest B- from CinemaScore and sits at 54 % on Rotten Tomatoes. The film, which dramatizes a whistle-blower’s expose of Facebook’s internal practices, received praise for its suspenseful pacing but was criticized for lacking the narrative weight of its 2010 predecessor, The Social Network. The original earned a 96 % rating and set a benchmark that the sequel has yet to approach.
What the weekend reveals about genre trends and upcoming releases
The stark disparity between a horror original and a tech-driven drama suggests that 2026 audiences remain drawn to visceral, high-concept scares even when critical consensus is unfavorable. Analysts note that the horror genre’s immunity to negative reviews often stems from a built-in fan base that values the experience of fright over critical endorsement. However, they also warn that the steep drop-off after the opening weekend may be imminent, especially for a title that earned a D+ CinemaScore.
Meanwhile, the tepid performance of The Social Reckoning raises questions about the theatrical viability of movies centered on corporate intrigue. Upcoming projects such as the Elizabeth Holmes documentary You Can See Everything and Luca Guadagnino’s Artificial (focused on OpenAI) are expected to debut primarily on streaming platforms, a strategy experts believe better suits their “dialogue-heavy” nature. Even well-produced tech dramas often lack the visual spectacle that drives theater attendance, making them better suited for at-home consumption.
Other holdovers, including the Resident Evil reboot—now at $138.5 million domestic and $300 million worldwide—demonstrate that franchise familiarity can sustain box-office momentum beyond opening weekend. Likewise, the limited-run documentary Musk earned just under $70 000 in its opening weekend, reinforcing the notion that niche biopics thrive in specialty venues rather than mass markets.
Studios may take note, allocating more resources toward high-concept genre pieces while reconsidering the theatrical rollout of tech-centric stories.
